Presentation TCT 2012 Do Patient and Stent Platform Specific Variables Matter (e.g. ACS vs. Stable CAD, First vs. Second Generation DES)? Presenter: Elvin Kedhi October 22, 2012
Presentation TCT 2012 TAVR Use Patterns on the European Continent: Growth, Penetration, and Reimbursement Presenter: Nicolo Piazza October 22, 2012
Presentation TCT 2012 New Data from PARTNER Continued Access (Non-randomized): Transapical Outcomes After TAVR Presenter: Todd Dewey October 22, 2012
Presentation TCT 2012 The Multidisciplinary Team: What Is Really Involved? Presenter: Michael Mack October 22, 2012
Presentation TCT 2012 Debate II. Should Renal Artery Stenting Only Be Done Using FFR and IVUS? Pro! Presenter: Mehdi Shishehbor October 22, 2012
Presentation TCT 2012 Provisional Stenting Technique: Step by Step Tutorial (Including Crossover Techniques) Presenter: Yves Louvard October 22, 2012
Presentation TCT 2012 The Case for Investing in a Hybrid Cath Lab/OR for TAVR Procedures Presenter: Mathew Williams October 22, 2012
Presentation TCT 2012 Ixmyelocel-T for CHF: Results of Catheter-based Study Presenter: Timothy Henry October 22, 2012
Presentation TCT 2012 Are COURAGE and FAME Irrelevant (or Less Relevant) with Current Generation DES? Presenter: Dean Kereiakes October 22, 2012
Presentation TCT 2012 Case 4: Percutaneous Repair of Thoracic Aortic Aneurysms Presenter: Sergey Abugov October 22, 2012